R. Shiri - Sverdlov

Lu, F., Groven, R. V. M., Meesters, D. M., Bitorina, A., Poeze, M., Tang, S., van Griensven, M., Blokhuis, T. J., & Shiri-Sverdlov, R. (2025). Cathepsin D and G expression correlates with human fracture healing phases and specific neutrophil N1 and N2 phenotypes. Bone, Article 117574. https://doi.org/10.1016/j.bone.2025.117574

Peters, L., Rakateli, L., Huchzermeier, R., Bonnin-Marquez, A., Maas, S. L., Lin, C., Jans, A., Geng, Y., Gorter, A., Gijbels, M., Rensen, S., Olinga, P., Hendrikx, T., Krawczyk, M., Brisbois, M., Jankowski, J., Bidzhekov, K., Weber, C., Biessen, E. A. L., ... van der Vorst, E. (2025). MicroRNA-26b protects against MASH development in mice and can be efficiently targeted with lipid nanoparticles. Elife, 13. https://doi.org/10.7554/eLife.97165

Vermeulen, I., Li, M., van Mourik, H., Yadati, T., Eijkel, G., Balluff, B., Godschalk, R., Temmerman, L., Biessen, E. A. L., Kulkarni, A., Theys, J., Houben, T., Cillero-Pastor, B., & Shiri-Sverdlov, R. (2025). Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction-associated steatohepatitis. FEBS Journal, 292(7), 1781-1797. https://doi.org/10.1111/febs.17358

Westheim, A. J. F., Dubois, L. J., Prades-Sagarra, E., van de Laak, J. G. M., van Mourik, H., Schuitmaker, L., Stoffels, L. M., Yaromina, A., van Dijk, M., van Bergenhenegouwen, J., van Helvoort, A., Langen, R. C. J., Shiri-Sverdlov, R., & Theys, J. (2025). Dietary enrichment with n-3 lc-PUFA-rich fish oil improves preclinical outcome of radiotherapy and anti-PD-L1 combination treatment. Cancer Treatment and Research Communications, 44, Article 100943. https://doi.org/10.1016/j.ctarc.2025.100943

Heymann, C. J. F., Mak, A. L., Holleboom, A. G., Verheij, J., Shiri-Sverdlov, R., van Mil, S. W. C., Tushuizen, M. E., Koek, G. H., & Grefhorst, A. (2024). The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease. Lipids in Health and Disease, 23(1), Article 402. https://doi.org/10.1186/s12944-024-02380-x

Li, M., Houben, T., Bitorina, A. V., Meesters, D. M., Israelsen, M., Kjærgaard, M., Koek, G. H., Hendrikx, T., Verbeek, J., Krag, A., Thiele, M., & Shiri-Sverdlov, R. (2024). Plasma cathepsin D as an early indicator of alcohol-related liver disease. JHEP Reports, 6(9), Article 101117. https://doi.org/10.1016/j.jhepr.2024.101117

Westheim, A. J. F., Stoffels, L. M., Dubois, L. J., van Bergenhenegouwen, J., van Helvoort, A., Langen, R. C. J., Shiri-Sverdlov, R., & Theys, J. (2023). The Modulatory Effects of Fatty Acids on Cancer Progression. Biomedicines, 11(2), Article 280. https://doi.org/10.3390/biomedicines11020280

van Mourik, H., Li, M., Baumgartner, S., Theys, J., & Shiri-Sverdlov, R. (2022). All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma. Biomedicines, 10(10), 1-19. Article 2351. https://doi.org/10.3390/biomedicines10102351

Westheim, A. J. F., Stoffels, L. M., Dubois, L. J., van Bergenhenegouwen, J., van Helvoort, A., Langen, R. C. J., Shiri-Sverdlov, R., & Theys, J. (2022). Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy. Frontiers in nutrition, 9, Article 868436. https://doi.org/10.3389/fnut.2022.868436

Mokkala, K., Gustafsson, J., Vahlberg, T., Vreugdenhil, A. C. E., Ding, L., Shiri-Sverdlov, R., Plat, J., & Laitinen, K. (2022). Serum CathepsinD in pregnancy: Relation with metabolic and inflammatory markers and effects of fish oils and probiotics. Nutrition Metabolism and Cardiovascular Diseases, 32(5), 1292-1300. https://doi.org/10.1016/j.numecd.2022.02.011